Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World StudyThomas B. Casale, Bradley E. Chipps, Allan T. Luskin et al.|The Journal of Allergy and Clinical Immunology In Practice|2018Cited by 277
The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticariaMarcus Maurer, Thomas B. Casale, Allen P. Kaplan et al.|Journal of Allergy and Clinical Immunology|2017Cited by 89
Bromodomain and Extra Terminal (BET) Inhibitor Suppresses Macrophage-Driven Steroid-Resistant Exacerbations of Airway Hyper-Responsiveness and InflammationThi Hiep Nguyen, Ming Yang|PLoS ONE|2016Cited by 23
The granulocyte colony-stimulating factor promotes atherosclerosis in high-fat diet rabbitsHu Zhang, Ning Zhou, Lei Li et al.|Heart|2011Cited by 3